These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6081272)

  • 21. Promethazine-chlorpromazine combination in the treatment of unmanageable psychotic patients.
    Favazza AR
    Henry Ford Hosp Med J; 1969; 17(4):305-10. PubMed ID: 5364067
    [No Abstract]   [Full Text] [Related]  

  • 22. Chlorpromazine metabolism in chronic schizophrenics.
    Sved S; Perales A; Palaic D
    Br J Psychiatry; 1971 Dec; 119(553):589-96. PubMed ID: 5143655
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients.
    Curry SH; Marshall JH
    Life Sci; 1968 Jan; 7(1):9-17. PubMed ID: 5636632
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitation of chlorpromazine and its metabolites by two-dimensional thin-layer chromatography and direct scanning microdensitometry.
    Turano P; Turner WJ
    J Chromatogr; 1972 Feb; 64(2):347-54. PubMed ID: 5013113
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum prolactin levels in newly admitted psychiatric patients.
    Meltzer HY; Sachar EJ; Frantz AG
    Adv Biochem Psychopharmacol; 1974; 12(0):299-315. PubMed ID: 4422003
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder.
    Dean B; Digney A; Sundram S; Thomas E; Scarr E
    Psychiatry Res; 2008 Feb; 158(1):75-8. PubMed ID: 18096247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorpromazine metabolism. I. Quantitative fluorometric method for 11 chlorpromazine metabolites.
    Kaul PN; Conway MW; Clark ML; Huffine J
    J Pharm Sci; 1970 Dec; 59(12):1745-9. PubMed ID: 5499704
    [No Abstract]   [Full Text] [Related]  

  • 28. Gas-liquid chromatographic analysis of phenolic and non-phenolic chlorpromazine metabolites in the urine of chronic schizophrenic patients.
    Kelsey MI; Moscatelli EA
    J Chromatogr; 1973 Oct; 85(1):65-74. PubMed ID: 4754405
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorpromazine metabolism in humans. Part I. Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct scan spectrodensitometry.
    Chan TL; Gershon S
    Mikrochim Acta; 1973; (3):435-52. PubMed ID: 9121390
    [No Abstract]   [Full Text] [Related]  

  • 31. Qualitative and quantitative report on chlorpromazine and metabolites in plasma, erythrocytes and erythrocyte washings from chronically medicated schizophrenic patients.
    Turano P; March JE; Turner WJ; Merlis S
    J Med; 1972; 3(2):109-20. PubMed ID: 4507068
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipsychotic efficacy of fluotracen: a clinical trial.
    Levy MI; Kendler KS; Mathé AA; Mohs RC; Denigris Y; Trigos GG; Axiotis A; Rothpearl A; Davis KL
    J Clin Psychopharmacol; 1983 Jun; 3(3):189-92. PubMed ID: 6135723
    [No Abstract]   [Full Text] [Related]  

  • 33. Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
    March JE; Donato D; Turano P; Turner WJ
    J Med; 1972; 3(3):146-62. PubMed ID: 4508254
    [No Abstract]   [Full Text] [Related]  

  • 34. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
    Stimmel GL; Falloon IR
    J Clin Psychiatry; 1983 Nov; 44(11):420-2. PubMed ID: 6643405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy.
    Kaiya H; Tamura Y; Adachi S; Moriuchi I; Namba M; Tanaka M; Yoshida H; Yanaihara N; Yanaihara C
    Psychiatry Res; 1981 Aug; 5(1):11-21. PubMed ID: 6169105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorpromazine metabolism. 3. Determination of conjugated metabolites in the blood of schizophrenic patients.
    Kaul PN; Conway MW; Ticku MK; Clark ML
    J Lab Clin Med; 1973 Mar; 81(3):467-75. PubMed ID: 4686960
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors affecting chlorpromazine plasma levels in psychiatric patients.
    Curry SH; Davis JM; Janowsky DS; Marshall JH
    Arch Gen Psychiatry; 1970 Mar; 22(3):209-15. PubMed ID: 5413268
    [No Abstract]   [Full Text] [Related]  

  • 38. Loxapine succinate: a comparative study with chlorpromazine.
    Dube KC; Kumar N
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):653-60. PubMed ID: 819223
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.
    Bratfos O; Haug JO
    Acta Psychiatr Scand; 1979 Jul; 60(1):1-9. PubMed ID: 382750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
    Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
    Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.